Published in Hum Mol Genet on September 22, 2000
Poly(A)-binding proteins: multifunctional scaffolds for the post-transcriptional control of gene expression. Genome Biol (2003) 4.45
3' end mRNA processing: molecular mechanisms and implications for health and disease. EMBO J (2008) 2.67
The behaviour of polyamino acids reveals an inverse side chain effect in amyloid structure formation. EMBO J (2002) 2.59
TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J Neurol Neurosurg Psychiatry (2008) 2.07
Loss of nuclear poly(A)-binding protein 1 causes defects in myogenesis and mRNA biogenesis. Hum Mol Genet (2009) 1.25
Poly(A) binding protein nuclear 1 levels affect alternative polyadenylation. Nucleic Acids Res (2012) 1.23
A Drosophila model of oculopharyngeal muscular dystrophy reveals intrinsic toxicity of PABPN1. EMBO J (2006) 1.18
Polyadenylation-dependent control of long noncoding RNA expression by the poly(A)-binding protein nuclear 1. PLoS Genet (2012) 1.15
In vivo aggregation properties of the nuclear poly(A)-binding protein PABPN1. RNA (2005) 1.13
The cell biology of disease: FSHD: copy number variations on the theme of muscular dystrophy. J Cell Biol (2010) 1.10
Amyloidogenesis of natively unfolded proteins. Curr Alzheimer Res (2008) 1.08
FRG1P-mediated aggregation of proteins involved in pre-mRNA processing. Chromosoma (2006) 1.07
RNA-mediated toxicity in neurodegenerative disease. Mol Cell Neurosci (2012) 1.07
A polyalanine tract expansion in Arx forms intranuclear inclusions and results in increased cell death. J Cell Biol (2004) 1.05
Trinucleotide expansions leading to an extended poly-L-alanine segment in the poly (A) binding protein PABPN1 cause fibril formation. Protein Sci (2003) 0.95
RNA-binding proteins and gene regulation in myogenesis. Trends Pharmacol Sci (2011) 0.95
Deregulation of the ubiquitin-proteasome system is the predominant molecular pathology in OPMD animal models and patients. Skelet Muscle (2011) 0.94
Modeling oculopharyngeal muscular dystrophy in myotube cultures reveals reduced accumulation of soluble mutant PABPN1 protein. Am J Pathol (2011) 0.93
PABPN1: molecular function and muscle disease. FEBS J (2013) 0.92
Implications of polyadenylation in health and disease. Nucleus (2014) 0.92
Antiprion drugs 6-aminophenanthridine and guanabenz reduce PABPN1 toxicity and aggregation in oculopharyngeal muscular dystrophy. EMBO Mol Med (2011) 0.91
RNA-binding proteins in neurodegenerative disease: TDP-43 and beyond. Wiley Interdiscip Rev RNA (2011) 0.90
A decline in PABPN1 induces progressive muscle weakness in oculopharyngeal muscle dystrophy and in muscle aging. Aging (Albany NY) (2013) 0.89
Poly(A) Polymerase and the Nuclear Poly(A) Binding Protein, PABPN1, Coordinate the Splicing and Degradation of a Subset of Human Pre-mRNAs. Mol Cell Biol (2015) 0.88
A yeast model for polyalanine-expansion aggregation and toxicity. Mol Biol Cell (2011) 0.86
Reducing bodies and myofibrillar myopathy features in FHL1 muscular dystrophy. Neurology (2011) 0.86
Interactions between homopolymeric amino acids (HPAAs). Protein Sci (2007) 0.84
Mechanistic insight into the pathology of polyalanine expansion disorders revealed by a mouse model for X linked hypopituitarism. PLoS Genet (2013) 0.84
Depletion of nuclear poly(A) binding protein PABPN1 produces a compensatory response by cytoplasmic PABP4 and PABP5 in cultured human cells. PLoS One (2012) 0.83
Poly(A) RNA-binding proteins and polyadenosine RNA: new members and novel functions. Wiley Interdiscip Rev RNA (2014) 0.83
Mitochondrial dysfunction reveals the role of mRNA poly(A) tail regulation in oculopharyngeal muscular dystrophy pathogenesis. PLoS Genet (2015) 0.83
Alternative splicing and muscular dystrophy. RNA Biol (2010) 0.83
Polyalanine-independent conformational conversion of nuclear poly(A)-binding protein 1 (PABPN1). J Biol Chem (2012) 0.82
A folded and functional protein domain in an amyloid-like fibril. Protein Sci (2008) 0.82
Executive functions are impaired in heterozygote patients with oculopharyngeal muscular dystrophy. J Neurol (2011) 0.82
Structural and functional alterations of muscle fibres in the novel mouse model of facioscapulohumeral muscular dystrophy. J Physiol (2007) 0.82
pH-dependent self-assembly of polyalanine peptides. Biophys J (2006) 0.82
Oculopharyngeal muscular dystrophy as a paradigm for muscle aging. Front Aging Neurosci (2014) 0.81
Phylogenetic and molecular characterization of the splicing factor RBM4. PLoS One (2013) 0.80
Oculopharyngeal Weakness, Hypophrenia, Deafness, and Impaired Vision: A Novel Autosomal Dominant Myopathy with Rimmed Vacuoles. Chin Med J (Engl) (2016) 0.78
Influence of the stability of a fused protein and its distance to the amyloidogenic segment on fibril formation. PLoS One (2010) 0.78
Progressive myopathy in an inducible mouse model of oculopharyngeal muscular dystrophy. Neurobiol Dis (2011) 0.78
Nuclear entrapment and extracellular depletion of PCOLCE is associated with muscle degeneration in oculopharyngeal muscular dystrophy. BMC Neurol (2013) 0.78
Frequent missense and insertion/deletion polymorphisms in the ovine Shadoo gene parallel species-specific variation in PrP. PLoS One (2009) 0.78
Giant poly(A)-rich RNP aggregates form at terminal regions of avian lampbrush chromosomes. Chromosoma (2015) 0.77
PABPN1-Dependent mRNA Processing Induces Muscle Wasting. PLoS Genet (2016) 0.76
Nuclear poly(A)-binding protein aggregates misplace a pre-mRNA outside of SC35 speckle causing its abnormal splicing. Nucleic Acids Res (2016) 0.76
Comparative analysis of the Shadoo gene between cattle and buffalo reveals significant differences. PLoS One (2012) 0.76
Alanine repeats influence protein localization in splicing speckles and paraspeckles. Nucleic Acids Res (2014) 0.76
Processing and transcriptome expansion at the mRNA 3' end in health and disease: finding the right end. Pflugers Arch (2016) 0.75
PABPN1 gene therapy for oculopharyngeal muscular dystrophy. Nat Commun (2017) 0.75
Conformational stability of the RNP domain controls fibril formation of PABPN1. Protein Sci (2015) 0.75
An Antibody to Detect Alanine-Expanded PABPN1: A New Tool to Study Oculopharyngeal Muscular Dystrophy. J Neuromuscul Dis (2015) 0.75
Conformational behavior of polyalanine peptides with and without protecting groups of varying chain lengths: population of PP-II structure! J Mol Model (2015) 0.75
An alanine expanded PABPN1 causes increased utilization of intronic polyadenylation sites. NPJ Aging Mech Dis (2017) 0.75
Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis. Science (2009) 13.45
Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol (1997) 5.48
Retinoic acid regulates aberrant nuclear localization of PML-RAR alpha in acute promyelocytic leukemia cells. Cell (1994) 5.37
The small nucleolar RNP protein NOP1 (fibrillarin) is required for pre-rRNA processing in yeast. EMBO J (1991) 4.93
Moderate expansion of a normally biallelic trinucleotide repeat in spinocerebellar ataxia type 2. Nat Genet (1996) 4.16
The C-terminal domain of TAP interacts with the nuclear pore complex and promotes export of specific CTE-bearing RNA substrates. RNA (2000) 3.96
Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet (1998) 3.62
Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene. Cell (1987) 3.60
A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat Genet (2001) 3.59
LRRTM1 on chromosome 2p12 is a maternally suppressed gene that is associated paternally with handedness and schizophrenia. Mol Psychiatry (2007) 3.49
Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature (1988) 3.27
The FERM domain: a unique module involved in the linkage of cytoplasmic proteins to the membrane. Trends Biochem Sci (1998) 3.24
REF proteins mediate the export of spliced and unspliced mRNAs from the nucleus. Proc Natl Acad Sci U S A (2001) 3.10
Mutations in the laminin alpha 2-chain gene (LAMA2) cause merosin-deficient congenital muscular dystrophy. Nat Genet (1995) 3.05
Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies. J Cell Biol (1995) 2.93
Cloning and intracellular localization of the U2 small nuclear ribonucleoprotein auxiliary factor small subunit. Proc Natl Acad Sci U S A (1992) 2.82
Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy. Cell (1994) 2.60
Dbp5, a DEAD-box protein required for mRNA export, is recruited to the cytoplasmic fibrils of nuclear pore complex via a conserved interaction with CAN/Nup159p. EMBO J (1999) 2.58
Assembly of a processive messenger RNA polyadenylation complex. EMBO J (1993) 2.58
Mutations in a gene encoding a novel protein tyrosine phosphatase cause progressive myoclonus epilepsy. Nat Genet (1998) 2.51
Inefficient processing impairs release of RNA from the site of transcription. EMBO J (1999) 2.50
The deadenylating nuclease (DAN) is involved in poly(A) tail removal during the meiotic maturation of Xenopus oocytes. EMBO J (1998) 2.49
Isolation of precursor cells (PCs) from human dental follicle of wisdom teeth. Matrix Biol (2005) 2.47
Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide. Am J Psychiatry (1999) 2.45
Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment. J Neurosci (2001) 2.43
Evolutionary conservation of the human nucleolar protein fibrillarin and its functional expression in yeast. J Cell Biol (1991) 2.39
Poly(A) tail shortening by a mammalian poly(A)-specific 3'-exoribonuclease. J Biol Chem (1997) 2.38
Vesicular stomatitis virus matrix protein inhibits host cell gene expression by targeting the nucleoporin Nup98. Mol Cell (2000) 2.33
Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22. Nature (1987) 2.32
A herpes simplex virus type 1 immediate-early gene product, IE63, regulates small nuclear ribonucleoprotein distribution. Proc Natl Acad Sci U S A (1993) 2.31
The coiled body. Trends Cell Biol (1993) 2.29
Purification of the cleavage and polyadenylation factor involved in the 3'-processing of messenger RNA precursors. J Biol Chem (1991) 2.25
Targeting of U2AF65 to sites of active splicing in the nucleus. J Cell Biol (1997) 2.21
The spinal muscular atrophy disease gene product, SMN: A link between snRNP biogenesis and the Cajal (coiled) body. J Cell Biol (1999) 2.17
Adenovirus replication and transcription sites are spatially separated in the nucleus of infected cells. EMBO J (1994) 2.12
Microinjection of anti-coilin antibodies affects the structure of coiled bodies. J Cell Biol (1998) 2.09
TAP (NXF1) belongs to a multigene family of putative RNA export factors with a conserved modular architecture. Mol Cell Biol (2000) 2.07
Contribution of TARDBP mutations to sporadic amyotrophic lateral sclerosis. J Med Genet (2008) 2.00
Cap-dependent deadenylation of mRNA. EMBO J (2000) 1.96
Poly(A) tail metabolism and function in eucaryotes. J Biol Chem (1993) 1.93
Transformation-mediated ductility in CuZr-based bulk metallic glasses. Nat Mater (2010) 1.92
In vivo evidence that TATA-binding protein/SL1 colocalizes with UBF and RNA polymerase I when rRNA synthesis is either active or inactive. J Cell Biol (1996) 1.90
Mutations in FUS cause FALS and SALS in French and French Canadian populations. Neurology (2009) 1.87
Population history and its impact on medical genetics in Quebec. Clin Genet (2005) 1.85
High resolution deletion analysis of constitutional DNA from neurofibromatosis type 2 (NF2) patients using microarray-CGH. Hum Mol Genet (2001) 1.79
Unusual sites of arginine methylation in Poly(A)-binding protein II and in vitro methylation by protein arginine methyltransferases PRMT1 and PRMT3. J Biol Chem (1999) 1.77
Mutation spectrum and predicted function of laforin in Lafora's progressive myoclonus epilepsy. Neurology (2000) 1.73
Precursor RNAs harboring nonsense codons accumulate near the site of transcription. Mol Cell (2001) 1.72
Type of mutation in the neurofibromatosis type 2 gene (NF2) frequently determines severity of disease. Am J Hum Genet (1996) 1.70
Deficiency of the 50K dystrophin-associated glycoprotein in severe childhood autosomal recessive muscular dystrophy. Nature (1992) 1.70
Systematic resequencing of X-chromosome synaptic genes in autism spectrum disorder and schizophrenia. Mol Psychiatry (2010) 1.69
Molecular mechanisms involved in cisplatin cytotoxicity. Cell Mol Life Sci (2000) 1.69
Immunodetection of poly(A) binding protein II in the cell nucleus. Exp Cell Res (1994) 1.67
Purification and characterization of poly(A) polymerase from Saccharomyces cerevisiae. J Biol Chem (1991) 1.67
A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS. Neurology (2009) 1.67
Immunolocalization and developmental expression of dystrophin related protein in skeletal muscle. Neuromuscul Disord (1991) 1.65
Nuclear polyadenylation factors recognize cytoplasmic polyadenylation elements. Genes Dev (1994) 1.64
Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis. Eur J Hum Genet (2002) 1.56
Compound heterozygous D90A and D96N SOD1 mutations in a recessive amyotrophic lateral sclerosis family. Ann Neurol (2001) 1.55
Dopaminergic neurotransmission and restless legs syndrome: a genetic association analysis. Neurology (2001) 1.54
Hereditary spastic paraplegia: advances in genetic research. Hereditary Spastic Paraplegia Working group. Neurology (1996) 1.50
The mechanism of 3' cleavage and polyadenylation of eukaryotic pre-mRNA. Prog Nucleic Acid Res Mol Biol (1997) 1.50
Cisplatin inhibits synthesis of ribosomal RNA in vivo. Nucleic Acids Res (1998) 1.49
Dynamic organization of splicing factors in adenovirus-infected cells. J Virol (1995) 1.48
Patterns of gene expression in the limbic system of suicides with and without major depression. Mol Psychiatry (2007) 1.47
Anticipation in familial cavernous angioma: ascertainment bias or genetic cause. Acta Neurol Scand (1998) 1.46
Differential interaction of splicing snRNPs with coiled bodies and interchromatin granules during mitosis and assembly of daughter cell nuclei. J Cell Biol (1994) 1.44
Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum Mol Genet (1994) 1.42
Mutations in GJB6 cause hidrotic ectodermal dysplasia. Nat Genet (2000) 1.42
Recombinant congenic strains derived from A/J and C57BL/6J: a tool for genetic dissection of complex traits. Genomics (2001) 1.42
Genome-wide association study of Tourette's syndrome. Mol Psychiatry (2012) 1.42
The rules and roles of nucleocytoplasmic shuttling proteins. FEBS Lett (2001) 1.42
[Oculopharyngeal muscular dystrophy: study of patients from seven Spanish families with different GCG expansions in PABP2 gene]. Neurologia (2004) 1.42
Rare mutations in N-methyl-D-aspartate glutamate receptors in autism spectrum disorders and schizophrenia. Transl Psychiatry (2011) 1.40
Lack of association between bipolar disorder and tyrosine hydroxylase: a meta-analysis. Am J Med Genet (1997) 1.40
Identification of gene products programmed by restriction endonuclease DNA fragments using an E. coli in vitro system. Nucleic Acids Res (1981) 1.40
Recent advances in the genetics of distal hereditary motor neuropathy give insight to a disease mechanism involving copper homeostasis that may extend to other motor neuron disorders. Clin Genet (2011) 1.39
A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians. Am Heart J (2001) 1.37
Frequency of spinocerebellar ataxia type 1, dentatorubropallidoluysian atrophy, and Machado-Joseph disease mutations in a large group of spinocerebellar ataxia patients. Neurology (1996) 1.36
Neurofibromatosis 2 tumor suppressor protein colocalizes with ezrin and CD44 and associates with actin-containing cytoskeleton. J Cell Sci (1997) 1.33
GATA transcription factors associate with a novel class of nuclear bodies in erythroblasts and megakaryocytes. EMBO J (1996) 1.32
Schizophrenia and chromosome 6p. Am J Med Genet (1997) 1.31
Localisation of splicing snRNPs in mammalian cells. Mol Biol Rep (1993) 1.31
Nuclear inclusions in oculopharyngeal dystrophy. Acta Neuropathol (1980) 1.31
A homologue of dystrophin is expressed at the neuromuscular junctions of normal individuals and DMD patients, and of normal and mdx mice. Immunological evidence. FEBS Lett (1991) 1.30
Identification of a major susceptibility locus for restless legs syndrome on chromosome 12q. Am J Hum Genet (2001) 1.30
Deciphering the cellular pathway for transport of poly(A)-binding protein II. RNA (2000) 1.29
Nuclear organization of splicing small nuclear ribonucleoproteins in adenovirus-infected cells. J Virol (1993) 1.28
Cerebral cavernous malformations: mutations in Krit1. Neurology (2002) 1.27
Oculopharyngeal muscular dystrophy. Semin Neurol (1999) 1.27
Characterization of monoclonal antibodies to calpain 3 and protein expression in muscle from patients with limb-girdle muscular dystrophy type 2A. Am J Pathol (1998) 1.25
Excess of deletions of maternal origin in the DiGeorge/velo-cardio-facial syndromes. A study of 22 new patients and review of the literature. Hum Genet (1995) 1.25
Primary adhalinopathy (alpha-sarcoglycanopathy): clinical, pathologic, and genetic correlation in 20 patients with autosomal recessive muscular dystrophy. Neurology (1997) 1.21
The nuclear poly(A) binding protein, PABP2, forms an oligomeric particle covering the length of the poly(A) tail. J Mol Biol (2000) 1.21
Cloning of a balanced translocation breakpoint in the DiGeorge syndrome critical region and isolation of a novel potential adhesion receptor gene in its vicinity. Hum Mol Genet (1995) 1.20